HIV and STD Prevention Update. New CDC Guidelines for HIV Post exposure Prophylaxis
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

HIV and STD Prevention Update. New CDC Guidelines for HIV Post exposure Prophylaxis
Filetype[HTM]


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Description:
    These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18 30, 2009. The information in this report updates the 2006 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 2006;55[No. RR 11]). Included in these updated guidelines is new information regarding 1) the expanded diagnostic evaluation for cervicitis and trichomoniasis; 2) new treatment recommendations for bacterial vaginosis and genital warts; 3) the clinical efficacy of azithromycin for chlamydial infections in pregnancy; 4) the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; 5) lymphogranuloma venereum proctocolitis among men who have sex with men; 6) the criteria for spinal fluid examination to evaluate for neurosyphilis; 7) the emergence of azithromycin-resistant Treponema pallidum; 8) the increasing prevalence of antimicrobial-resistant Neisseria gonorrhea; 9) the sexual transmission of hepatitis C; 10) diagnostic evaluation after sexual assault; and 11) STD prevention approaches.
  • Collection(s):
    Guidelines and Recommendations
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.17 MB]
    Personal Author:
    Dominguez, Kenneth L.; Smith, Dawn K.; Vasavi Thomas,; Crepaz, Nicole; Lang, Karen; Heneine, Walid; McNicholl, Janet M.; Reid, Laurie; Freelon, Brandi; Nesheim, Steven R.; Huang, Ya-lin (Aileen); Weidle, Paul J.;
    Published Date:
    April 18, 2016, Update (May 23, 2018)
    Description:
    Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP). Please see attached statement (PDF of Dolutegravir attached)From the Centers for Disease Control and Prevention, ...
    Status:
    current
    File Type:
    Filetype[PDF - 1.17 MB]
  2. Filetype[PDF - 1.67 MB]
    Corporate Authors:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group..
    Published Date:
    March 2018
    Description:
    The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure ...
    Status:
    current
    File Type:
    Filetype[PDF - 1.67 MB]
  3. Filetype[PDF - 464.63 KB]
    Personal Author:
    Nelson, Noele
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group..
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
    Published Date:
    3/26/18
    Series:
    ACIP meeting Hepatitis Vaccines
    Description:
    Presentations February 2018 Day 1Publication date from document properties.Hepatitis-04-Nelson-508.pdf
    File Type:
    Filetype[PDF - 464.63 KB]
  4. Filetype[PDF - 215.93 KB]
    Personal Author:
    De Cock, Kevin M.; Holtgrave, David R.; Janssen, Robert S.; Smith, Dawn K.;
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of HIV/AIDS Prevention--Surveillance and Epidemiology.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    September 25, 1998
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 47, no. RR-17
    Description:
    The most effective methods for preventing human immunodeficiency virus (HIV) infection are those that protect against exposure to HIV. Preventive behaviors include sexual abstinence, sex only with an uninfected partner, consistent and correct condom ...
    File Type:
    Filetype[PDF - 215.93 KB]
  5. Filetype[PDF - 248.88 KB]
    Personal Author:
    Curran, James W.; Jaffe, Harold W.; Janssen, Robert S.; Ward, John W.;
    Corporate Authors:
    National Center for Infectious Diseases (U.S.). Division of HIV/AIDS.. Centers for Disease Control and Prevention (U.S.). National Center for Prevention Services (U.S.). Division of STD/HIV Prevention..
    Published Date:
    January 15, 1993
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 42, no. RR-2
    Description:
    These recommendations update previous recommendations regarding human immunodeficiency virus (HIV) counseling and testing of patients in acute-care hospital settings (1). The revision was prompted by additional information regarding both the rates at...
    Status:
    superseded
    File Type:
    Filetype[PDF - 248.88 KB]